+4415180811362023: Volume 8, Issue 3
Perspective P.1-2
Therapeutic potential and risks of hallucinogenic substances.
Author(s): Jones Robert*
DOI: 10.35841/aajpc-8.3.176
Short Communication P.1-2
The psychology of Huntington's disease: Understanding the emotional and behavioural challenges of living with the condition.
Author(s): Ethane Chan*
DOI: 10.35841/aajpc-8.3.177
Rapid Communication P.1-2
Mental health matters: Prioritizing wellness in the modern world.
Author(s): Andersson Mikael*
DOI: 10.35841/aajpc-8.3.178
Short Communication P.1-2
Nootropics changing the way we think about cognitive enhancement.
Author(s): Chen Zihan*
DOI: 10.35841/aajpc-8.3.179
Opinion Article P.1-2
The adverse effects of living with Parkinson′s disease.
Author(s): Xiao Wen*
DOI: 10.35841/aajpc-8.3.180
Short Communication P.1-2
Exploring the complexities of abnormal psychology: Understanding and treating mental health disorders.
Author(s): Margarita Sala*
DOI: 10.35841/aajpc-8.3.171
Rapid Communication P.1-2
Alcohol use disorder: The struggle with alcohol use disorder and paths to healing.
Author(s): John Strang*
DOI: 10.35841/aajpc-8.3.172
Commentary P.1-2
The science and use of antipsychotic medications in mental health treatment.
Author(s): Andreas Heinz*
DOI: 10.35841/aajpc-8.3.173
Perspective P.1-2
The transformative powers, science and culture of hallucinogenic substances.
Author(s): Georges Naasan*
DOI: 10.35841/aajpc-8.3.174
Opinion Article P.1-2
The psychology of learning: Techniques and strategies for enhancing cognitive abilities.
Author(s): Courtney Berezuke*
DOI: 10.35841/aajpc-8.3.175